2BBBullish & Bearish
Health Care

Quest Diagnostics Incorporated Common Stock (DGX) Stock Score & Signals

Quest Diagnostics Incorporated Common Stock (DGX) trades on NYSE. It operates in the Health Care sector, Diagnostics & Research industry. Its current 2BB score is 45 out of 100.

About Quest Diagnostics Incorporated Common Stock

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.

2BB score and signals

Quest Diagnostics Incorporated Common Stock’s current 2BB score is 45 out of 100, built from the signal categories below.

SignalScoreReading
Activity34Low
Momentum45Stable
Financial strength67Strong
Quality100Very Strong
Risk33Low

Company facts

CEOJames E. Davis
Founded1967
Employees51.5K
P/E ratio26.00
52-week range$171.18 – $247.19

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-082.6995$3.03B
2026-10-192.8811$3.07B
2026-07-232.8535$3.00B
2026-04-212.52.369$2.90B$2.86B